Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 13 de 13
Filtrar
1.
Int J Oral Maxillofac Surg ; 33(8): 733-9, 2004 Dec.
Artigo em Inglês | MEDLINE | ID: mdl-15556319

RESUMO

The results are presented of eight patients who had partial mandibulectomies for malignant tumours and were secondarily reconstructed with pre-shaped 2.3 mm titanium plates, autogenous particulate cortico-cancellous bone grafts and platelet rich plasma. Healing was uneventful in all cases and when prosthodontically needed, implants were inserted after approximately 6 months, whilst biopsies were taken. The histology showed bone remodelling in six cases, whilst in one case after 6 months the bone was largely replaced by abundant fibrous tissue. In this case the implants were lost after 9 months. In one case a new carcinoma developed after 6 months with subsequent death of the patient. Thus, in six patients adequate results were achieved with adequate functional and aesthetic outcome, given the poor conditions of the surrounding tissues. This method provides three-dimensional reconstruction with sufficient bone height and volume to facilitate prosthodontic treatment.


Assuntos
Materiais Biocompatíveis , Placas Ósseas , Transplante Ósseo , Mandíbula/cirurgia , Transfusão de Plaquetas , Titânio , Idoso , Remodelação Óssea/fisiologia , Carcinoma de Células Escamosas/patologia , Implantes Dentários , Falha de Restauração Dentária , Estética Dentária , Feminino , Seguimentos , Humanos , Masculino , Neoplasias Mandibulares/cirurgia , Pessoa de Meia-Idade , Recidiva Local de Neoplasia/patologia , Procedimentos de Cirurgia Plástica , Transplante Autólogo , Cicatrização/fisiologia
10.
Transfus Sci ; 14(2): 195-7, 1993 Apr.
Artigo em Inglês | MEDLINE | ID: mdl-10148612

RESUMO

Platelet refractoriness in treatment of multitransfused patients with haematologic malignancies can be delayed or prevented by transfusing leukocyte-poor platelet concentrates. Absence of consensus about the number of residual leukocytes that leads to a delay or prevention of HLA-antibody formation, may be based on a lack of sampling for determination of leukocyte contamination levels in platelet concentrates. From data presented in this study we conclude that if every preparation of platelets is also tested for platelet count, it reduces costs when the pheresis platelets can be split. Transfusion of platelets in patients can also be better evaluated.


Assuntos
Remoção de Componentes Sanguíneos/métodos , Transfusão de Plaquetas , Plaquetoferese/métodos , Remoção de Componentes Sanguíneos/instrumentação , Transfusão de Componentes Sanguíneos/instrumentação , Transfusão de Componentes Sanguíneos/métodos , Antígenos HLA , Humanos , Contagem de Leucócitos/instrumentação , Contagem de Leucócitos/métodos , Países Baixos , Contagem de Plaquetas/instrumentação , Contagem de Plaquetas/métodos , Plaquetoferese/instrumentação , Plaquetoferese/normas
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...